LIMITATIONS
lymphedema, breast cancer
LYMPHEDEMA, SECONDARY, COMPLICATION, BREAST CANCER
There are some limitations in this study. On the one hand, the subjects in this study were limited to breast cancer patients receiving treatment in one hospital. The sampling range and sample size were limited. In addition, due to time constraints, this study only evaluated the effect of intervention for 4 months without continuous follow‐up investigation, and the long‐term effects of lymphedema prevention interventions cannot be judged. As lymphedema is a secondary complication, the incidence may increase with the influence of time or radiotherapy after chemotherapy, so the negative result may be caused by the short follow‐up time in this study.